Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Neal davidson who wrote (793)	5/17/1999 4:02:00 PM
From: Gabriel Louli	Read Replies (1) \| Respond to of 2344

Speculation based on current info is all anybody has to go on - is there any other source of tangible information you can point to?

To: Neal davidson who wrote (793)	5/17/1999 4:23:00 PM
From: StockMiser	Read Replies (2) \| Respond to of 2344

At the time that I wrote that, the stock price was being supported by several MM's, keeping it in a tight range. Once they left...the price dropped (just as I had mentioned it would). It wasn't speculation...just direct observation. I personally watched USCT pick up around 80K shares, all above $5. I was neither a buyer nor seller today (as was the case of many longs). I'm still awaiting further exposure for BIOM. The results of Theratope study used for stem cell replacement patients were nothing short of spectacular - it doubled life expectancy. I seriously expect this particular study to gain further exposure over the next week or so. Let me also remind you that the CEO was, in fact, interviewed by the NY Times - that is NOT a rumor. That the article will appear in conjunction with the ASCO was the rumor. In any case, I am in for the long haul. BIOM's time will come...and I don't think we'll have to wait much longer. The word is slowly getting out there... SM